发明名称 Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
摘要 Disclosed herein is a quinoxalinyl macrocyclic compound of formula (I), wherein G is defined as -NS(O)2-R3 and all other substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Such compounds are useful in the treatment of hepatitis C viral infections or for the inhibition of the replication of the hepatitis C virus.
申请公布号 NZ573275(A) 申请公布日期 2011.12.22
申请号 NZ20070573275 申请日期 2007.06.26
申请人 ENANTA PHARMACEUTICALS, INC. 发明人 OR, YAT SUN;MOORE, JOEL, D;LIU, DONG;SUN, YING;GAI, YONGHUA;TANG, DATONG;NIU, DEQIANG;XU, GUOYOU;WANG, ZHE
分类号 A61K31/4965 主分类号 A61K31/4965
代理机构 代理人
主权项
地址